News Focus
News Focus
icon url

seekinganswers

11/07/25 8:36 AM

#796709 RE: Doc logic #796708

Sigmund Freud would have a field day with this post.
Best Wishes.
icon url

manibiotech

11/07/25 9:08 AM

#796711 RE: Doc logic #796708

None of what you just wrote makes sense .

"good news she could have disclosed in 2015 regarding the screening hold which, obviously for fiduciary and strategic reasons she chose not to"

You know this because of extensive discussions with the management ?? Because fiduciary duty would have required to do the exact opposite .

Before you claim some restrictions to release the news to protect integrity of the trial etc , then why wasn't the reason disclosed after last patient was enrolled/recruited, or after the data was locked , or after final results were published or even after submission to RA.

You are again throwing pure assumptions almost as facts with no evidence to back up your speculation
icon url

LessIsMore

11/07/25 9:34 AM

#796716 RE: Doc logic #796708

Linda had good news she could have disclosed in 2015 regarding the screening hold

A new low, this reeks of desperation.
icon url

learningcurve2020

11/07/25 10:13 AM

#796727 RE: Doc logic #796708

That’s just crazy talk

At that time she said bad actors turned “good news” into “bad news” and that happened because the “good news” was never disclosed to anyone publicly and those privately aware, time has shown us, were obviously not allowed to trade based on this information.

Yeah sure, great news! 🙄From their filing:

>>Since we did not enroll the last 17 of the planned 348 patients, this could adversely affect the statistical and other analyses of our Phase Ill trial results and could make it more difficult to seek product approval or more likely that further trials could be required. There can be no assurance that regulatory authorities will allow a product approval to be based upon this approach.